Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015 https://t.co/CkxoGhE0uz
RT @chngin_the_wrld: Today's #shoutout to #WomeninSTEM goes to Sandra Bulens for her @CDC_EIDjournal paper on surveillance of carbapenem-no…
RT @chngin_the_wrld: Today's #shoutout to #WomeninSTEM goes to Sandra Bulens for her @CDC_EIDjournal paper on surveillance of carbapenem-no…
RT @chngin_the_wrld: Today's #shoutout to #WomeninSTEM goes to Sandra Bulens for her @CDC_EIDjournal paper on surveillance of carbapenem-no…
Today's #shoutout to #WomeninSTEM goes to Sandra Bulens for her @CDC_EIDjournal paper on surveillance of carbapenem-nonsusceptible Acinetobacter baumannii in 8 US Metropolitan Areas, 2012–2015 https://t.co/gSOuku3Zyh #AMR #antibioticResistance #superbugs #
RT @A_baumannii: ICYMI: Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015. https://t.co/Vb9bMWt0nV http…
While Acinetobacter baumanii infections are rare, treatment is difficult and death rates are high. Learn more in #EIDjournal - https://t.co/mGzEhS36hK
ICYMI: Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015. https://t.co/Vb9bMWt0nV https://t.co/GLNFBPFhbX
2/2 88.3% occurred among patients with exposure to a healthcare facility during the preceding year; 84.6% patients had an indwelling device; https://t.co/AMTmXC0LHK
Orphan disease market size: CDC data on carbapenem-nonsusceptible Acinetobacter baumannii: incidence of 1.4 (1.2-1.6) per 100,000 = 4620 est cases/year in USA. https://t.co/AMTmXC0LHK 1/2
While Acinetobacter baumanii infections are rare, treatment is difficult and death rates are high. Learn more in #EIDjournal - https://t.co/mGzEhRLvqc
While Acinetobacter baumanii infections are rare, treatment is difficult and death rates are high. Learn more in #EIDjournal - https://t.co/07MI9jwSSv
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015. https://t.co/PZTJr00MEE https://t.co/osPcPasMIG
While Acinetobacter baumanii infections are rare, treatment is difficult and death rates are high. Learn more in #EIDjournal - https://t.co/07MI9jwSSv
Want to stay healthy? Stay away from hospitals. Study shows nearly all A.baumannii infections are hospital-acquired. https://t.co/AoERs27FIA
Ahead of Print -Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015 - Volume... https://t.co/CaAvFGZ5vy
Ahead of Print -Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015 - Volume 24, Number 4—April 2018 - Emerging Infectious Disease journal - CDC https://t.co/oZpITgRorO via @CDCgov
Ahead of Print -Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015 - Volume 24, Number 4—April 2018 - Emerging Infectious Disease journal - CDC https://t.co/0ZgQkTTA4L